PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Curadigm SAS, 60 rue de wattignies, 75012 Paris, France. Electronic address: matthieu.germain@curadigm.com.\', \'Department of Biotechnology and Nanomedicine, SINTEF Industry, 7465 Trondheim, Norway.\', \'LIFNano Therapeutics, 10 Fendon Road, University of Cambridge Clinical School, Cambridge CB1 7RT, UK.\', \'Nanotech Lab, Te.Far.T.I., Department of Life Sciences, University of Modena and Reggio Emilia, Via Campi 103, 41124 Modena, Italy.\', \'Gesellschaft fuer Bioanalytik Muenster e.V., Mendelstrasse 17, 48151 Muenster, Germany.\', \'ETPN association, 64-66 rue des archives, 75003 Paris, France.\', \'Department of Clinical Chemistry and Haematology, University Medical Centre Utrecht, 3584, CX, Utrecht, the Netherlands.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0168-3659(20)30382-510.1016/j.jconrel.2020.07.007
?:doi
?:hasPublicationType
?:journal
  • Journal of controlled release : official journal of the Controlled Release Society
is ?:pmid of
?:pmid
?:pmid
  • 32681950
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Delivering the power of nanomedicine to patients today.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32681950>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32681950>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all